maxarray™ prostate cancer & bph tissue microarray slides Search Results


90
Thermo Fisher maxarray™ prostate cancer & bph tissue microarray slides
Maxarray™ Prostate Cancer & Bph Tissue Microarray Slides, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/maxarray™ prostate cancer & bph tissue microarray slides/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
maxarray™ prostate cancer & bph tissue microarray slides - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thermo Fisher maxarray prostate cancer & bph tissue microarray slides
Maxarray Prostate Cancer & Bph Tissue Microarray Slides, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/maxarray prostate cancer & bph tissue microarray slides/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
maxarray prostate cancer & bph tissue microarray slides - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
Thermo Fisher immunofluorescence microscopy maxarray prostate cancer bph tissue microarray slides
Immunofluorescence Microscopy Maxarray Prostate Cancer Bph Tissue Microarray Slides, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunofluorescence microscopy maxarray prostate cancer bph tissue microarray slides/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
immunofluorescence microscopy maxarray prostate cancer bph tissue microarray slides - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
Eppley Laboratory Inc frozen prostate tumors
Frozen Prostate Tumors, supplied by Eppley Laboratory Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/frozen prostate tumors/product/Eppley Laboratory Inc
Average 90 stars, based on 1 article reviews
frozen prostate tumors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
FUJIFILM vevo 2200 photoacoustic scanner
Vevo 2200 Photoacoustic Scanner, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vevo 2200 photoacoustic scanner/product/FUJIFILM
Average 90 stars, based on 1 article reviews
vevo 2200 photoacoustic scanner - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies prostate tumor
Prostate Tumor, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prostate tumor/product/Agilent technologies
Average 90 stars, based on 1 article reviews
prostate tumor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biomax Inc tumor, prostate tumor
Tumor, Prostate Tumor, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor, prostate tumor/product/Biomax Inc
Average 90 stars, based on 1 article reviews
tumor, prostate tumor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare prostate tumors
Prostate Tumors, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prostate tumors/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
prostate tumors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SuperBioChips commercial prostate tumor tissue microarrays
Commercial Prostate Tumor Tissue Microarrays, supplied by SuperBioChips, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/commercial prostate tumor tissue microarrays/product/SuperBioChips
Average 90 stars, based on 1 article reviews
commercial prostate tumor tissue microarrays - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Shionogi rat prostate tumors
Rat Prostate Tumors, supplied by Shionogi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat prostate tumors/product/Shionogi
Average 90 stars, based on 1 article reviews
rat prostate tumors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biomax Inc prostate tumor tissue microarray pr1921a
Prostate Tumor Tissue Microarray Pr1921a, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prostate tumor tissue microarray pr1921a/product/Biomax Inc
Average 90 stars, based on 1 article reviews
prostate tumor tissue microarray pr1921a - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation cancer pathwayfinder
In vivo therapeutic and chemopreventive effects of ASC-J9 in genetically engineered mouse PCa models. A: Early treatment with ASC-J9 suppressed tumor initiation/progression in the <t>TRAMP</t> mouse model. The chemopreventive effects of ASC-J9 were demonstrated by early i.p. injection at 8 weeks old with continued treatment until 23 to 24 weeks old. The prostates (prostate tumors or precancerous lesions) were harvested and photographed (left panel), and the prostate mass weights were calculated (right panel). N = 6 mice per group. B: ASC-J9 treatment suppressed the growth of TRAMP tumor chunks <t>s.c.</t> <t>implanted</t> into SCID mice. After 4 weeks of vehicle or ASC-J9 injection, the s.c. tumors were harvested and photographed (top panel), and the tumor weights were calculated (bottom panel). N = 6 for each group. C: TRAMP prostate tumor growth was inhibited by ASC-J9 after subrenal capsule implantation in SCID mice. After 4 weeks of vehicle or ASC-J9 injection, tumors were harvested and photographed (left panel), and the tumor weights were determined (right panel). N = 3 for each group. D: ASC-J9 displayed chemopreventive effects in the Pten+/− mouse model. ASC-J9 was administrated to 6-month-old Pten+/− mice, and the dorsolateral prostates were harvested 2 months after injection. Histologic examination of 8-month-old Pten+/+ DMSO, Pten+/− DMSO, and Pten+/− ASC-J9–treated prostates were subjected to H&E staining (left panel). The arrows point to the high-grade PIN lesions. Quantitation of high-grade PIN lesions is provided in the right panel. N = 5 to 6 mice per group. Error bars = mean ± SEM. Scale bars: 200 μm (original magnification, ×100) and 50μm (original magnifcation, ×400).
Cancer Pathwayfinder, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cancer pathwayfinder/product/SuperArray Bioscience Corporation
Average 90 stars, based on 1 article reviews
cancer pathwayfinder - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


In vivo therapeutic and chemopreventive effects of ASC-J9 in genetically engineered mouse PCa models. A: Early treatment with ASC-J9 suppressed tumor initiation/progression in the TRAMP mouse model. The chemopreventive effects of ASC-J9 were demonstrated by early i.p. injection at 8 weeks old with continued treatment until 23 to 24 weeks old. The prostates (prostate tumors or precancerous lesions) were harvested and photographed (left panel), and the prostate mass weights were calculated (right panel). N = 6 mice per group. B: ASC-J9 treatment suppressed the growth of TRAMP tumor chunks s.c. implanted into SCID mice. After 4 weeks of vehicle or ASC-J9 injection, the s.c. tumors were harvested and photographed (top panel), and the tumor weights were calculated (bottom panel). N = 6 for each group. C: TRAMP prostate tumor growth was inhibited by ASC-J9 after subrenal capsule implantation in SCID mice. After 4 weeks of vehicle or ASC-J9 injection, tumors were harvested and photographed (left panel), and the tumor weights were determined (right panel). N = 3 for each group. D: ASC-J9 displayed chemopreventive effects in the Pten+/− mouse model. ASC-J9 was administrated to 6-month-old Pten+/− mice, and the dorsolateral prostates were harvested 2 months after injection. Histologic examination of 8-month-old Pten+/+ DMSO, Pten+/− DMSO, and Pten+/− ASC-J9–treated prostates were subjected to H&E staining (left panel). The arrows point to the high-grade PIN lesions. Quantitation of high-grade PIN lesions is provided in the right panel. N = 5 to 6 mice per group. Error bars = mean ± SEM. Scale bars: 200 μm (original magnification, ×100) and 50μm (original magnifcation, ×400).

Journal: The American Journal of Pathology

Article Title: New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells

doi: 10.1016/j.ajpath.2012.10.029

Figure Lengend Snippet: In vivo therapeutic and chemopreventive effects of ASC-J9 in genetically engineered mouse PCa models. A: Early treatment with ASC-J9 suppressed tumor initiation/progression in the TRAMP mouse model. The chemopreventive effects of ASC-J9 were demonstrated by early i.p. injection at 8 weeks old with continued treatment until 23 to 24 weeks old. The prostates (prostate tumors or precancerous lesions) were harvested and photographed (left panel), and the prostate mass weights were calculated (right panel). N = 6 mice per group. B: ASC-J9 treatment suppressed the growth of TRAMP tumor chunks s.c. implanted into SCID mice. After 4 weeks of vehicle or ASC-J9 injection, the s.c. tumors were harvested and photographed (top panel), and the tumor weights were calculated (bottom panel). N = 6 for each group. C: TRAMP prostate tumor growth was inhibited by ASC-J9 after subrenal capsule implantation in SCID mice. After 4 weeks of vehicle or ASC-J9 injection, tumors were harvested and photographed (left panel), and the tumor weights were determined (right panel). N = 3 for each group. D: ASC-J9 displayed chemopreventive effects in the Pten+/− mouse model. ASC-J9 was administrated to 6-month-old Pten+/− mice, and the dorsolateral prostates were harvested 2 months after injection. Histologic examination of 8-month-old Pten+/+ DMSO, Pten+/− DMSO, and Pten+/− ASC-J9–treated prostates were subjected to H&E staining (left panel). The arrows point to the high-grade PIN lesions. Quantitation of high-grade PIN lesions is provided in the right panel. N = 5 to 6 mice per group. Error bars = mean ± SEM. Scale bars: 200 μm (original magnification, ×100) and 50μm (original magnifcation, ×400).

Article Snippet: C: The Superarray (Cancer PathwayFinder) was used to identify gene expression changes in s.c. implanted TRAMP prostate tumors treated with vehicle or ASC-J9.

Techniques: In Vivo, Injection, Staining, Quantitation Assay